New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management- Surveillance Study for Adverse Effects
NCT00490932
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
27966
Enrollment
OTHER
Sponsor class
Conditions
Diarrhea
Dysentery
Interventions
DRUG:
Hypo-osmolar ORS
Sponsor
Society for Applied Studies